Loading…
Loading…

| KALV | KalVista Pharmaceuticals, Inc. | $27.00 | $1.4B |
| OMER | Omeros Corporation | $19.37 | $1.4B |
| LXRX | Lexicon Pharmaceuticals, Inc. | $2.32 | $1.0B |
| RAPT | RAPT Therapeutics, Inc. | $58.01 | $959.3M |
| FDMT | 4D Molecular Therapeutics, Inc. | $15.03 | $785.7M |
| PRTA | Prothena Corporation plc | $9.07 | $474.8M |
| CMPX | Compass Therapeutics, Inc. | $2.47 | $443.9M |
| FULC | Fulcrum Therapeutics, Inc. | $3.85 | $293.4M |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $1.50 | $278.6M |
| ADCT | ADC Therapeutics S.A. | $1.13 | $143.7M |